Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial
Volume 63, Issue 6, June 2024, 107164Author links open overlay panel, , , , , , , , , , , , , , , , , , , Highlights•The c...